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ABSTRACT Histamine covalently bound to glutaraldehyde-activated ferritin was prepared as
either monomers or as small aggregates of -0.05 to 0.15 p,m Diam, suitable for electron
microscopic detection of histamine cellular binding sites. The histamine-ferritin conjugates
(MF) maintain the histamine capability to induce the opening of endothelial junctions in
venules. To investigate the distribution of histamine receptors in the vascular endothelium,
monomers or aggregates of MF were perfused in situ (mice), and various vascular beds,
particularly that of the diaphragm, were fixed and processed for electron microscopy. The
conjugate was preferentially bound on restricted areas of luminal endothelial cell plasmalemma
especially in regions rich in filaments, and near the junctions between endothelial cells. The
density of histamine binding sites was characteristically high in venules; it occurred to a much
lesser extent in arterioles, veins, and muscular arteries whereas capillaries and aorta showed
the lowest values. A similar distribution was obtained after perfusion of H, or H2 receptor
agonists coupled to ferritin (2-pyridylethylamine-ferritin [PF], or 4-methylhistamine-ferritin
[MF], respectively). The binding specificity was assessed through control experiments with
either native or activated ferritin or by competition with histamine. The findings suggest that
histamine receptors are largely represented in the cell membrane of the vascular endothelium,
particularly in venules. Experiments using specific H, and H2 receptor agonists (PF and MF)
and antagonists (mepyramine and cimetidine) indicate that the venular endothelium contains
mainly H2 receptors.
Histamine participates in a number of physiological processes
particularly those of the cardiovascular system (1, 5, 6, 9, 32,
34) and is largely involved in inflammatory and anaphylactic
reaction (3, 4). As identified on a physiological and pharma-
cological basis, its effects are mediated by two types of recep-
tors: H, receptors, specifically inhibited by classical antihista-
mines such as mepyramine, and H2 receptors, blocked by
antagonists such as cimetidine (8, 19, 35). The distribution and
properties of histamine receptors (Hr) as defined for several
cells, tissues, and organs, including blood vessels, is based
primarily on the target responses to histamine either alone or
associated with its agonists or antagonists (7, 11-15, 18, 20, 33,
42,45).
Histamine receptors were demonstrated to be located on the
plasma membrane of several mammalian cells (10, 21, 22, 28,
29, 43). So far, theirpresence has been detected by the binding
of various cells to histamine which was either insolubilized on
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albumin-treated agarose beads (28, 46, 47), or coupled to
bovine serum albumin-fluorescein isothiocyanate (BSA-FITC)
(12) or o-phtaldialdehyde (30). An indirect detection of Hr was
acheived by determining the [3H]mepyramine binding (41).
The aim of the present study was (a) to produce an electron-
opaque, biologically active histamine conjugate, and (b) to
localize at the cellular level, the histamine receptors of the
microvascular endothelium.
The biologically active marker obtained was a histamine-
ferritin conjugate (HF) which could be produced as either
monomers or small aggregates. Results reported here show
that, as detected by HF binding, Hr are present on the plasma
membrane ofthe endothelial cellsparticularly in venules where
a remarkable number of high-affinity binding sites render the
venular endothelium a characteristically differentiated domain.
This can explain the special involvement of venules in inflam-
mation.
357MATERIALS AND METHODS
Materials
REAGENTS :
￿
Chemicals were purchased as follows: histamine diphosphate
from Sigma Chemical Co ., St . Louis, MO ; ferritin, 6x crystallized, cadmium
(removed from horse spleen) from Miles Laboratories Inc., Elkhart IN; glutar-
aldehyde, as a25% solution purified according to P . J . Anderson fromE . Merck,
Darmstadt, Germany; ['11](G)-histamine from New England Nuclear, Boston,
MA; Sephadex G25andSepharose 6B fromPharmaciaFineChemicals, Uppsala,
Sweden . 2-Pyridylethylamine dihydrochloride, 4-methylhistamine dihydrochlo-
ride, mepyramine maleate, and cimetidine were a generous gift ofDr. C . Robin
Ganellin from Smith, Kline, and French Laboratories LTD ., Welwyn Garden
City, England .
ANIMALS :
￿
164 RAP mice, weighing 20 g each, were kept under similar
standardized conditions of feeding and housing for 10 d before being used for
these experiments.
Methods
PREPARATION OF HISTAMINE-FERRITIN CONJUGATE :
￿
Ferritin was ac-
tivated according to the method of Kishida et al. (23) slightly modified in that a
340-fold molar excess ofglutaraldehyde per amino group ofapoferritin wasused:
7mg (0.1 ml) offerritin in 1.7 ml of 0.1Msodium phosphate buffer, pH 7.3 was
mixed with 0.4 ml of 25% glutaraldehyde solution . The reaction wastamed out
at 22'C for 30min, with stirring . The small amount of precipitate formed during
the reaction wasremoved by centrifugation at 20,000g for 10 min. The activated
ferritin was separated from the unreacted glutaraldehyde by gel chromatography
on a Sephadex G-25 coarse column (2.5x90cm) equilibrated andrapidly eluted
with 0.1 M sodium phosphate buffer, pH 7.3 at 4°C . The peak fractions of
activated ferritin were collected and concentrated-at 4°C-to -y3 mg/ml of
protein .
Thecoupling was achieved by incubating 10 mg of activated ferritin (in 3.2ml
ofsodium phosphate buffer) with 165mg ofhistamine diphosphate (in 0.8 ml of
sodium phosphate buffer) for 24 h, at 4°C, with gentle stirring. In some cases, at
the end ofthis period,4.3 mg ofNaBH, were added to reduce theC=N bonds ;
the reaction was completed in 15 min (27, 46), and the small amount ofresulting
insoluble polymers was removedby centrifugation at 8,000g for 5min .
PREPARATION OF HF MONOMERS :
￿
ThecrudeHF conjugatewas separated
from unbound histamine by gel filtration on a Sepharose 6B column (1 .3 x 80
cm) equilibrated and eluted with 0.1 M Tris-HC1 buffer, pH 7.5, at 4°C. The
peak fractions of HF conjugate were collected and concentrated-at 4°C-to
-1.5-2 mg/ml protein, and the purified product was stored at 4°C until used.
The solution can be stored foramonth at 4°C. The chromatographic separation
oftheHF monomers was also assessed by using ['-]histamine under conditions
identical to those previously mentioned (Fig. l). The unbound histamine could
also be removed by HF dialysis at 4'C against more than 300 vol of Tris-HCl
buffer, changed several times over 48 h .
PREPARATION OF HF AGGREGATES : The crude HF conjugate was di-
alyzed at 4°C against >300 vol of distilled water, changed several times over 48
h . Theresultingopalescent suspensionwas storedat4'C. (After extended storage,
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FIGURE 1 Chromatographic separation of histamine-ferritin con-
jugate from unbound histamine, tested by using [3H]histamine ;
Sepharose 68 column (1 .3 x 80 cm), equilibrated and eluted with
0.1 M Tris-HCI buffer, pH 7.5, at 4°C . HF monomers eluted as a
relatively sharp peak (A), followed by free [3H]histamine (peak B) .
FIGURE 2 Electrophoretic pattern (PAGE) of native ferritin, crude
HF conjugate, and HF monomers; the latter were obtained after gel
chromatography of the crude HF conjugate on a Sepharose 613
column . Conditions of the electrophoretic run are given under
Materials and Methods.
the solution should be thoroughly shaken) . Before use, the suspension was
dialyzed against an excess of0.15M NaCl and sonicated for 10min . Aliquots of
HF were examined with the electron microscope to determine their average
diameter and size distribution.
Control of the Purity of HF Conjugate
PAGE :
￿
Aliquots of HF conjugate (crude HF, and HF monomers [HFm])
were electrophoresed on slab gels containing 5% acrylamide in 0.6 M barbital
buffer,pH 8.5 to 8.6 . Electrophoresis was carried out in the same buffer for 8 h
at a field strength of3.5 mA/cm . Gels were then fixed overnight in a mixture of
45% methanol and 45% acetic acid, subsequently stained for I h with 0.03%
Coomassie Brilliant Blue R-250 in 24% (vol/vol) isopropanol, and 10% (vol/vol)
acetic acid, followed by a final destaining wash in the same isopropanol-acetic
acid solvent (40, 50) (Fig. 2) .
THIN-LAYER CHROMATOGRAPHY :
￿
The analysis of HF conjugates and
their components was carried out on plastic plates precoated with Kieselgel 60
F2~, 250 pin thick (E. Merck). The developing solvent was a mixture of 96%
ethanol (80 vol) and 25% ammonium hydroxyde (20 vol). For staining, 0.3%
ninhydrin in n-butanol (wt/vol) solution was used (39) (Fig. 3) .
IS0ELECTRIC FOCUSING : The method was applied to small samples of
ferritin, and HF monomers with or without NaBH, treatment . The procedure
was performed in a polyacrylamide gel containing 4.5% acrylamide and 2%
ampholytepH 3.5 to 10 (LKB Ampholine, LKB, Bromma, Sweden) . The anolyte
was 1 MH3P04 , and the catholyte IMNaOH . An LKBpower supply was used
to generate 320V at the beginning ofthe experiment ; voltage was increased to a
maximumof 870V(12W constant power) . The determination ofthe electrofo-
cusing point was done by using a stibium surface electrode . Gel fixation and
staining was carried out by the standard procedure (2, 49) .
ESTIMATION OF MOLAR RATIO :
￿
33 mg ofhistamine diphosphate contain-
ing 'H-histamine (final sp act: -I x 106 cpm/mg) in I ml ofsodium phosphate
buffer was coupled to 2 mg ofconcentrated, activatedferritin . The crude ['H]HF
conjugate was separated from unbound ['H]histamine bygel filtration under the
conditions mentioned above (Fig. 1) . Thefractions containing the conjugate were
collected and the protein concentration of['H]HF peak was determined by the
absorbante at 440 rim using an extinction coefficient(E,.) of 11 .6 . The radioac-
tivity in 0.5-nil aliquots from the collected fractions was determined in an L-100
C Beckman liquid scintillation counter (Beckman Instruments, Inc., Fullerton,
CA). Aliquots from thetwo peaks (A andB in Fig . 1) demonstrated anequivalent
quenching . The amount of histamine in the monomerc peak of conjugate (A)
wascalculated from the amount ofradioactivity present, based on the assumption
that ['I4]histamine reacted to the same extent as unlabeled histamine . Molar
concentrations ofhistamine and ferritin were calculated on the basis ofM r of 1 I I
and 440,000, respectively .Tests for the Biological Activity of HF Conjugate
CONTRACTION OF SMOOTH MUSCLE :
￿
It has been shown by Black et al .
(8) that histamine stimulates the contraction of smooth muscle from various
organs, such as ileum, uterus, andstomach . Such biological effect was assessed
forHF through Vane's method using the fundal portion ofthe rat stomach (44).
The fundal strip was suspended in a 10-ml bath containing Krebs' bicarbonate
solution (composition inmM: NaCl, 118.4 ; KCI, 4.7 ; CaCI 22H20, 1.9; NaHCOa,
25 .0; MgS07H20, 1 .2 ;KM2PO,2H 20, 0.1 ; glucose, 11 .7) warmed up at 37°C and
gassedwith 5% C02and95%02. Aftera 30-minstabilization period, the following
compounds were tested by adding one of them, once every 10-15 min, to the
organ bath : histamine diphosphate prepared immediately before use (5 lal; 2.7 x
10-3M as base), HF conjugate (50 lal; 0.5 mg protein), native ferritin (50 ul; 0.5
mg protein) andNaCl (50 f l; 0.15 M). The last two were used as controls. The
contractions were recorded on a polygraph and allowed to develop for 2-3 min
until restoring to the base level. After each test, the organ bath was washed out
by overflow (Fig. 4).
VENULAR LEAKAGE : As shown by Majno et al. (24-26) the topical or
systemic administration ofhistamine is followed by vascular leakage character-
istically restricted to venules . The capability of HF to induce a histammelike
effect was assessed throughtwo lines of experiments testing : (a)HF monomers'
capability to induce the extravasation of previously injected carbon black parti-
cles, and (b) extravasation at the level of venules ofsome of the intravascularly
administered HF aggregates (HFa) .
(a) Under general anesthesia, RAP mice were given an i.v. injection of 0.1
ml/100 g body weight carbon black (Pelikan Special Ink Black Cl1/1431A
Gunter Wagner, Pelikan Werke, Hanover, Germany) . After 2 min, aHF mono-
mers solution (0.15 mg bound histamine/100 g body weight) was administered
intravenously . 30minlater, thediaphragmwas fixed in situwith 5% formaldehyde
and 2% glutaraldehyde in 0.1 M HCI-Na arsenate buffer, pH 7.2 . Under the
dissecting microscope, the diaphragm was screened for black vascular "tattoo"
and the labeled regions were photographed for further measurements (38) .
(b) From experiments in whichHF aggregates were injected (see Experimen-
tal Procedure), regions ofdiaphragm containing well identified bipolar micro-
FIGURE 3
￿
Kieselgel thin-layer chromatogram for assessing the ab-
sence of unbound histamine in the HF conjugates (4 and 5) .
Developing solvent: 96% ethanol (80 vol) and 25% ammonium
hydroxyde (20 vol) ; staining: 0.3% ninhydrin in n-butanol (wt/vol) .
FIGURE 4
￿
Response of the fundal strip of the rat stomach to his-
tamine (H) and histamine-ferritin (HF) added to the organ bath in
the following concentrations : H 2 .7 x 10-7 M as base (51x1) ; HF,0 .5
mg protein (50 141) . Native ferritin ( F), 0 .5 mg protein (501x1) or NaCl,
0.15 M (501d) were used as controls . Arrowheads indicate the time-
point of washing out of the drug with Krebs' bicarbonate solution .
vascular fields (BMFs) were collected, processed for electron microscopy, and
examined for opened endothelial junctions (36, 37) .
Experimental Procedure
Mice were anesthetized with chloral hydrate (50mg/ 100 g body weight) given
intraperitoneally; the abdominal aortawas cannulatedwith a# 7405 polyethylene
tubing (I.D . 0.38 mm; Clay Adams-Becton Dickinson & Co ., Sharon, MA)
connected to a Harvard infusion pump securing a 2-3 ml/min perfusion flow.
The caudal vena cava was incised and used as outlet. Blood waswashed out by
perfusion of -20 ml of Dulbecco's phosphate-buffered saline (PBS) containing
1 mM Ca?' and supplemented with 14mM glucose. SmallHFa orHFm(20mg
protein/100 g body weight) were perfused for 3 min . The unbound conjugate
waswashed out ofvessels with -10ml ofthe same buffer. Fixation was carried
out for 5 min by perfusion of 2% glutaraldehyde in 0.1 M HCI-Na arsenate
buffer, pH 7.2 . All solutions used were prewarmed to 37°C. The observations
were focusedprimarily on thediaphragmatthelevelofwhichsequential vascular
segments (arteries, arterioles, capillaries, venules, and veins) can be reliably
identified under the dissecting microscope . Diaphragm was collected, photo-
graphed, andBMFs were excised and further processed for electron microscopy
as indicated in references 36-38 .
Controls
The specificity of HF binding was assessed by perfusmg the vasculature with
one ofthe following : (a) native ferritin; (b) activated ferritin (both solutions were
made in 0.15MNaCl, at a concentration of20 mg protein/100 g body weight,
and were given under the same conditions used for the basic experiments); (c)
competitive inhibition with histamine: a solution of 4 x 10-5 M/100 g body
weightwasmadein0.15MNaCland perfusedfor4minbefore the administration
ofHF conjugate.
Characterization of H, and/or H2 Receptors
Using Ferritin-Conjugated Agonists
H, andH2 receptor agonists were used to producetwo conjugates (as small
aggregates <_ 0.1 lm) :2-pyridylethylamine-ferritin (PF), and 4-methylhistamine-
ferritin (MF) . The coupling was achieved by incubating activated ferritin with
one of the two drugs, using the method described for the HF aggregates (see
above) . Thetwo conjugates stored at 4°C preserved their properties forup to 3
wk. As demonstrated by thin-layer chromatography, the suspensions of PF and
MF did not contain detectable amounts of free 2-pyridylethylamme and 4-
methylhistamine, respectively .
To characterize the H, andH2 receptors, five groups of experiments (using 2-
3 mice for each experiment) were carried out, in which one of the following
substances was administered under the same conditions as described for the basic
procedure: (a) perfusion of MF ; (b) perfusion of PF ; (c) perfusion ofcimetidine
before the administration ofHFa; (d) perfusion of cimetidine beforeMF admin-
istration; (e) perfusion of mepyramine before administration of PF . HFa, MF,
and, PF were given at a concentration of 20 mg protein/100 g body weight .
Mepyraminemaleate (as specific H, receptor antagonist) was prepared in isotonic
saline and perfused before PF (experiment e) at a concentration of 4 x 10 -5 M/
100 g body weight (as base) for 2 min. Cimetidine (as specific H2 receptor
antagonist) was prepared by disolving 252mg in 1.10 ml of 1MHCI, neutralized
with 2.0 ml of0.1 M NaOH, and brought to the desired dilution with isotonic
saline: the solution wasperfusedbefore HFa (experiment c) andMF (experiment
d) at a concentration of 4 x 10-'M/100 g body weight for 2min.
Tissue Processing for Electron Microscopy
Aorta, vena cava, renal artery, and the diaphragm were fixed in situ by
perfusion of2% glutaraldehyde in 0 .l M HCI-Na arsenatebuffer,pH 7.2, warmed
to 37°C . After 10 min, large vessels as well as bipolar microvascular fields ofthe
diaphragm (36-38) were excised under the dissecting microscope and further
immersed in the same fixative for an additional 80 min, and subsequently
processed for electron microscopy as indicated in reference 36. Sections cut with
adiamond knife on an American Optical Ultracut microtome (American Optical
Corp ., Buffalo, NY) or Reichert Ultramicrotome were stained with citrate and
examined with a Philips400electron microscope operating at 80kV . Microvessels
were identified according to the criteria used in reference 36 .
RESULTS
HF Conjugates
Electrophoretic analysis showed that the native ferritin and
the crude HF conjugate are resolved in three similar bands,
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359which in the case of the former compound were named a, ,8,
and y, and considered to correspond to apoferritin monomer,
dimer, and trimer, respectively (48). HF monomers chromato-
graphically separated on Sepharose 6B (peakA in Fig . 1), and
subsequently checked by electron microscope, appeared to
consist of two analogous components (Fig . 2) : a fast moving
component (a-band) containing >90% of the protein is repre-
sented by HF monomers, and a slower moving constituent
(,B-band) containing <100 1o of protein is formed byHF dimers .
As indicated by the chromatographic analysis of the crude
[ 3HJHF conjugate, the molar ratio of [3H]histamine to ferritin
in this conjugate is -60:1 to 80 :1 . Ferritin activation with more
than a 340-fold molar excess ofglutaraldehyde' did not increase
the histamine/ferritin molar ratio .
As demonstrated by thin-layer chromatography, the solution
ofHF conjugates did not contain a detectable amount of free
histamine (Fig . 3) . As compared to the pl 4.6 ofnative ferritin,
the isoelectric point of HF monomers is 5.3-5.5 when they
have not been treated with NaBH4 : such treatment brings the
pl to 6.8 .
HF conjugates, in either monomeric or aggregate form,
stored at4°C could be used for at least 2wk without significant
loss of bound histamine or biological effects.'
HF aggregates produced by exhaustive dialysis against water,
and sonicated for 10 min, represent a relatively heterogeneous
population ofsmall clusters ranging from -0.05-0.151ím ; they
sediment easily at 3,000 g. The availability of these small
aggregates allowed a much larger sampling of vessels labeled
by HF conjugate, especially those vascular segments provided
with high-affinity binding sites for histamine. The HF aggre-
gates obtained only by dialysis against distilled water presented
large diameters ranging from -r0.2-0 .5 ,um . By perfusion of
such HF large aggregates, one could produce false labeling due
to artifactual plugging of microvessels; to avoid this, the HFa
suspension was again dialyzed against 0.15 M NaCl and soni-
cated for 10 min before use .
Biological Activity of HF Conjugate
HF conjugate maintained its capability to induce a hista-
minelike effect, namely the contraction of smooth muscle from
rat stomach (Fig. 4) . The preparation was sensitive neither to
native ferritin nor to 0.15M NaCl added to the organ bath.
At high doses, both HF monomers and HF aggregates
maintained their capability to induce venular leakage at the
level ofwhich open endothelialjunctions allowed extravasation
of carbon black or HF aggregates . The subsequent intramural
deposits developed preferentially in venules of 15- to 30-1ím
Diam. In electron microscopic preparations, the affected ven-
ules showed typical focal separations of endothelial junctions
through which the injected HF aggregates gained access to
subendothelial spaces (Fig. 5) . In control experiments, after
their systemic injection, neither the native ferritin nor activated
ferritin induced detectable vascular leakage.
' The excess of glutaraldehyde used for ferritin activation prevents the
formation of ferritin-ferritin polymers during the first step of the
reaction (23) .
'The stability ofthe HF conjugatemaybe explained by the extensive
cross-linkage introduced by glutaraldehyde, as a result of stable Mi-
chael-type additions formed between amino groups and a, ,ß-unsatu-
rated aldehydes (23, 31) .
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FIGURE 5
￿
Mousediaphragm, 3min after perfusion of HF aggregates
(a) : muscular venule displaying focal opening of an endothelial
junction (") with HF aggregates (arrows) sequestrated within the
subendothelial space (ss), against the basal lamina (bl) . e,, and e2 ,
the adjoining endothelial cells, l, lumen . x 90,000 .
HF Binding on the Luminal Aspect of the
Microvascular Endothelium
The existence ofBMFs in the mouse diaphragm allowed the
examination of the distribution of histamine receptors in well-
identified sequential microvascular segments: i .e . arterioles,
capillaries, and venules (36) .
HF MONOMERS :
￿
In specimens obtained from animals per-
fused with HFm, the conjugate was found on restricted areas
of the luminal front of endothelial cell plasmalemma . The
conjugate appeared as monomers and, occasionally, as dimers
(Figs . 6 and 7) . The HF binding occurred mostly on those
regions ofthe endothelial cells rich in filaments, especially the
parajunctional areas (Fig. 8a, b) . Occasionally, the HF mono-
mers were found associated with plasmalemmal vesicles and
coated pits, a process that was not significantly influenced
either by the histamine antagonists or by histamine. In the
BMFs of the diaphragm, HF binding was particularly promi-
nent in venules, specially postcapillary (pericytic) venules, to a
much lesser extent in arterioles and almost inconspicuous in
capillaries . Aorta, veins, and muscular arteries from random
specimens showed a low HF binding affinity.
HF AGGREGATES :
￿
In experiments with small aggregates,
the electron microscope examination of thin sections from the
arteriolar and venular level of BMFs specimens revealed the
same localization ofHFa as observed in theHFm experiments.
The small aggregates appeared bound particularly to those
parts of the venular endothelial cells which contained a rela-
tively large number of cytoplasmic filaments or were located
next to the parajunctional areas (Fig. 9) . In specimens in which
relatively large aggregates (0.2 to 0.5 Am Diam) have been
used, the binding of the latter to venular endothelium produced
a sharp decoration which could be detected by light microscope
examination of cross sections (Fig . 11) . The density of such
labeling, however, was not always sufficient to render these
vessels visible with the dissecting microscope . In cases in which
such decoration occurred, it was frequently due to a combina-
tion of specific binding and, in addition, a partial plugging of
the vessel lumen by large aggregates . For this reason we focusedour observations on experiments with HF monomers and HF
small aggregates .
Control Experiments
Neither the native ferritin nor the activated ferritin bound
specifically to endothelial cell plasmalemma . Preliminary esti-
mates indicated that the number ofHF monomers (or dimers)
bound to the luminal aspect of vascular endothelium is -12-
to 15-fold more numerous than the nonspecific attachment of
native or activated ferritin. Artifactual aggregates of native or
activated ferritin did not bind conspicuously to the endothelial
cell membrane . Previous perfusion with 4 X 10-5M histamine
resulted in the inhibition ofHF conjugate binding to venular
(high-affinity sites) and arteriolar (low-affinity sites) endothe-
lium .
Characterization of H, and H2 Receptors
The binding ofPF and MF conjugates (as small aggregates)
on endothelial cell membrane of different microvessels (in
BMFs) was recorded as the average number of binding sites
per square micrometer (Table I) . PF and MF distribution was
found to mimic the localization ofHF conjugate on the luminal
front of the endothelial cell plasmalemma: postcapillary (peri-
cytic) venules presented characteristic high-affinity sites for the
two specific H, and H2 receptor agonists (Fig . 10) . In venules,
MF binding (6.6 ± 0.94) was approximately twice as intensive
as PF binding (3 .1 t 1 .38) . The percentage of MF and PF
binding, out of the sum ofMF and PF binding, was 68.0 and
31.9, respectively, presumably corresponding to the fractional
distribution ofH2 and H, receptors in venular endothelium .
Cimetidine (H2 receptor antagonist) perfused before HFa
administration, inhibited almost completely the binding of the
latter to the venular (and arteriolar) endothelium. When given
before MF perfusion, cimetidine abolished completely the
binding of this histamine agonist conjugate to the venular
endothelium . The same results were also obtained when me-
pyramine was used before PF perfusion.
These finding support the idea that, at least in mouse dia-
phragm, the response of venular endothelium is mediated by
both types of receptors, the H2 receptors being predominant.
DISCUSSION
HF conjugate results from the coupling of the amino group of
histamine to the glutaraldehyde-activated amino residues of
ferritin. In the conjugate, histamine preserves its vasoactive
activity probably by conversion to a secondary amine .
HF binding capacity cannot be ascribed to its slightly mod-
ified pI (5.6 as compared to 4.6 for the native ferritin) because,
on the one hand, at this pI, ferritin itself does not bind to the
endothelium, and on the other hand, it has been shown that
both free histamine and histamine bound to a carrier display
equipotent vasoactive effects independent of the charge char-
acteristics of the conjugate (46, 47).
FicUREs 6 and 7 Postcapillary (pericytic) venules of mouse diaphragm, 3 min after perfusion of HF monomers . The latter
(arrowheads) are bound to the luminal aspect of the endothelial cell, especially in its parajunctional zone (Fig . 6) as well as on the
peripheral area (Fig . 7) . Occasionally, HF monomers are taken up by plasmalemmal vesicles (v) . bl, basal lamina, e, endothelial
cell, j, intercellular junction, /, lumen, p, pericyte . Fig . 6 : X 123,000 ; Fig . 7 : X 94,000.
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361FIGURE 8
￿
Venules of the mouse diaphragm, 3 min after perfusion of HF monomers . The conjugate is bound to a relatively high
density on the luminal endothelial cell membrane in the parajunctional area (arrowheads) of both pericytic (a) and muscular
venules (b) . bl, basal lamina, e, endothelial cell, j, endothelial junction, 1, lumen . (a) x 125,000; (b) x 138,000.
FIGURE 9
￿
Pericytic venule of a mouse diaphragm, 3 min after perfusion of HFa: aggregates of relatively small size (a) are bound
to the endothelial cell membrane, often corresponding to cell regions containing filaments (arrowhead) . bl, basal lamina, e,
endothelium, 1, lumen . x 116,000.
FIGURE 10
￿
Pericytic venule in a BMF of mouse diaphragm, 3 min after perfusion of 4-methylhistamine-ferritin conjugate : small
aggregates of the conjugate (arrowheads), bound at relatively high density, on the luminal endothelial cell membrane . bl, basal
lamina, l, lumen, ps, perivascular space, m, muscle, e, endothelium . x 104,000.
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amined with the light microscope . HF aggregates (arrowheads) label
specifically the luminal endothelial surface of the venule (v),
whereas the capillary lumina (c) are unlabeled . x 1,075 .
The fact that HF preserves the biological activity of the
histamine suggests that the imidazol portion of the molecule-
which is critical for recognition by receptor, particularly H2
receptor'-was not changed by the coupling .
The results obtained indicate that the luminal aspect of
vascular endothelium contains membrane receptors for hista-
mine . They are especially well-represented in venules (both
pericytic and muscular), at the level of which the aggregate
area of histamine receptors represents a highly differentiated
domain of the plasma-lemma . Hr are preferentially localized
in cell regions rich in filaments, including the parajunctional
zones . This might confirm Majno's original assumption that
the opening of the venular junctions induced by histamine is
due to the contraction of intracytoplasmic filaments (24-26) .
The possible implication of other factors (e.g . the contraction
of pericytes and smooth muscle cells) has to be demonstrated .
The search forHr on the abluminal front of vascular endothe-
lium (presumably the first to "see" the histamine released by
mast cells) will show whether the high density of Hr detected
on the luminal plasmalemma results at least in part from their
migration in the plane of the membrane, with subsequent
aggregation at the sites of histamine stimuli .
Despite the large representation of HF binding sites in the
venules of various vascular beds, the distribution observed in
mouse diaphragm may not represent a ubiquitous pattern ; the
3 Atautomeric ring system capable ofprotonexchange is a requirement
forH2 but not forH, receptor stimulants (19) .
TABLE I
Specific Binding of HFa, MF, and Pf in the Microvessels
(BMFs) of theMouse Diaphragm
Conjugate Total Arterioles Capillaries Venules
(as aggre-
gates)
￿
(%J (%) (%)
HF 17.7±1 .24 1.2t0.66* 4.5±0.85 12.0±2.20
(6 .8) (25.4) (67.8)
MF 11 .5±0.52 1.4±0.25 3.5t0.38 6.6±0.94
(12.2) (30.4) (57.4)
PF
￿
6.4±0.82
￿
1 .3
￿
2.0±0.26
￿
3.1 t 1.38
(20.3) (31.3) (48.4)
MF+PFf 17.9±0.67 2.7
￿
5.5±0.32 9.7±1 .16
(l5.1) (30.7) (54.2)
Measurements were made on 6 to 9 BMFs for each experimental condition .
In each BMF, the average number of vascular profiles examined were: 2-4
arterioles, 4-12 capillaries, and 6-12 venules. In each vascular profile, the
endothelial cell surface (luminal front) examined was in the range of 0.3-3 .0
pin' . The binding was expressed as the average number of histamine binding
sites per square micrometer.
*Mean t SEM ; in brackets, the percentage of binding in a given type of
vessel, out of the total recorded for the microvascular bed of the BMF .
$The values represent the sum of the binding figures recorded separately in
MF and PF experiments (see Materials and Methods) .
particulars of the detailed Hr distribution in other vasculature
isnow under investigation.
At least as revealed by the present findings, the receptor-
mediated control ofarterioles by histamine could be related to
theendothelium but only by low-affinity sites.
The marked chemical distinction betweenHl andH2 recep-
tor agonists (9, 13) and the considerable receptor selectivity of
their antagonists (8, 33, 35) allows a reliable identification of
the type of Hr present in vascular endothelium. Our results
indicate that histamine effects on the cardiovascular system are
mediated by both typesof Hr; in ventiles the prevailing type is
the H2 receptors . The mechanism of the cooperation between
Ht and H2 receptors and the related cyclic AMP or GMP
changes during thebiphasic histamine effects on venules is still
unclear. However, our observations indicate that histamine
action on venular endothelium is receptor-mediated and that
theH2 receptors appear to be an important component of the
inflammatory condition . The opening ofendothelial junctions
in venules, as a prerequisite of extravasation and diapedesis,
may be a complex process in which histamine participates by
inducing the contraction of filaments (probably followed by
relaxation) (4) which represent a common denominator in
endothelial cells, pericytes, and smooth muscle cells .
Perfusion of specific histamine receptor antagonists impeded
thebindingand the subsequent formation of plugs ofHF large
aggregates. These findings support the idea that this kind of
massive decoration implies an initial specific binding of HF
conjugate . A procedure for the controlled decoration of vas-
cular segments in mouse diaphragm (as a biological or phar-
macological test for assessing the antihistaminic activity of
different drugs) is now under investigation (16, 17) .
Preliminary accounts of some of the findings reported in this paper
were presented at the Second International Congress on Cell Biology,
West Berlin, August 1980,and at theAnnual Meeting of the American
Society for Cell Biology, Cincinatti, OH., November 1980, and pub-
lished in abstract form in Eur. J . Cell Biol . (16), and J . Cell Biol. (17) .
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the Smith, Kline, and French Laboratories Ltd., England, for the
generous supply of 2-pyridylethylamine dihydrochloride, 4-methyl-
histamine dihydrochloride, mepyramine maleate, and cimetidine used
in these studies .
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